biologics

‘Breakthrough’ mAb in moderate to severe bullous pemphigoid

Biologics safe and effective for young patients with AD

Why do psoriasis patients switch biologics?

Genes predict the best biologics for psoriasis

Predictors of multiple biologic failure in psoriasis

IL-23 inhibitors for psoriasis best at preventing arthritis development

Monoclonal antibody hope for hidradenitis suppurativa

Biologics improve psoriasis but not CV risk
